Home Orexigen Therapeutics resubmits Contrave to FDA
 

Keywords :   


Orexigen Therapeutics resubmits Contrave to FDA

2013-12-12 11:39:48| Biotech - Topix.net

The FDA refused to approve Contrave in 2011, citing concerns over cardiovascular risk.

Tags: fda therapeutics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11NIKE13FG
24.11adidas
24.11NIKE
24.116
24.11 (UK)CAP
24.11 (
24.11tt011/10 rc
24.11dorachama Lysin 32kg
More »